Avanos Medical
AVNS
272 hedge funds and large institutions have $1.53B invested in Avanos Medical in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 91 reducing their positions, and 37 closing their positions.
12% more capital invested
Capital invested by funds: $1.36B → $1.53B (+$165M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.89% less ownership
Funds ownership: 96.93% → 96.04% (-0.89%)
4% less call options, than puts
Call options by funds: $1.35M | Put options by funds: $1.42M
2% less funds holding
Funds holding: 277 → 272 (-5)
11% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 37
53% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 91
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$22.2M |
| 2 |
RC
RGM Capital
Naples,
Florida
|
+$12.5M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.64M |
| 4 |
AC
Armistice Capital
New York
|
+$6.3M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$3.35M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$15.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.23M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$6.97M |
| 4 |
BlackRock
New York
|
-$6.43M |
| 5 |
Goldman Sachs
New York
|
-$4.38M |
AVNS Hedge Fund Activity: Q3 2020 in Review
272 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2020, worth a combined $1.53B — up 12% from $1.36B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of AVNS and 33 opened new positions — a net loss of 4 holders — while 91 trimmed existing stakes and 43 added.
The largest buyer was Wellington Management Group, adding an estimated $22.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $15.9M.
- 272 institutional investors held Avanos Medical (AVNS) as of Q3 2020, down from 277 in Q2 2020.
- Funds reported $1.53B of Avanos Medical stock for Q3 2020, up 12% quarter-over-quarter.
- 33 funds opened new Avanos Medical positions in Q3 2020 and 37 closed out, a net change of -4 holders.
- The largest Avanos Medical buyer in Q3 2020 was Wellington Management Group, an estimated $22.2M added.
- The largest Avanos Medical seller in Q3 2020 was T. Rowe Price Associates, an estimated $15.9M sold.
Based on aggregated 13F filings for Q3 2020.